Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Patent
1994-09-02
1997-10-21
Kight, John
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
424831, 514 56, 514 61, 536 187, 536123, 5361231, A61K 31715, A61K 31725, A61K 3173, A61K 3902
Patent
active
056796544
ABSTRACT:
Methods and products for protecting against abscess formation associated with surgery, trauma or diseases that predispose the host to abscess formation are provided. Methods for forming immunomodulators and pharmaceutical compositions relating thereto also are provided. The products useful in the invention are polysaccharides including a repeat unit having a positively charged free amino group and a negatively charged group. The preferred polysaccharide is B. fragilis capsular polysaccharide A.
REFERENCES:
patent: 5158939 (1992-10-01), Takayama et al.
patent: 5576002 (1996-11-01), Jennings et al.
Tzianabos, A. et al., Structural basis for polysaccharide-mediated protection against intraabdominal abscess formation., Biological Abstracts 97:abstract No. 343438.
Tzianabos, A.O. et al., Structrual features of polysaccharides that induce intra-abdominal abscesses., Science 262:416-419 (1993).
Pantosti, A. et al., Immunochemical characterization of two surface polysaccharides of Bacteroides fragilis., Infect Immun. 59(6):2075-2082 (1991).
Baumannn, H. et al., Structural elucidation of two capsular polysaccharides from one strain of Bacteroides fragilis using high-resolution NMR spectroscopy., Biochemistry 31(16):4081-4089 (1992).
Tzianabos, A.O. et al., The capsular polysaccharide of Bacteroides fragilis comprises two ionically linked polysaccharides., J. Biol. Chem. 267(25):18230-18235 (1992).
Tzianabos, A.O. et al., Structural characteristics of polysaccharides that induce protection against intra-abdominal abscess formation., Infect. Immun. 62(11):4881-4886 (1994).
Tzianabos, A. O. et al., Polysaccharide-mediated protection against abscess formation in experimental intra-abdominal sepsis., J. Clin Invest 92:2727-2731 (1995).
Pavliak, V. et al. Structural elucidation of the capsular polysaccharide of Bacteroides fragilis strain 23745M1., Carbohydrate Res 275:333-341 (1995).
Tzianabos, A.O. et al., Structure and function of Bacteroides fragilis capsular polysaccharides: Relationship to induction and prevention of abscesses., Clin Infect Dis 20 (Suppl 2);S132-S140 (1995).
Tzainabos A.O. et al., Bacterial structure and functional relation to abcess formation., Infect Agents Dis 3:256-265 (1994).
Tzianabos, A.O. et al., Structure-function relationships of polysaccharide-induced intraabdominal abscesses., Infect Immun 62:3590-3593 (1994).
Crabb, J.H. et al., T cell reguation of Bacteroides fragilis-induced intraabdominal abscesses., Rev Infect Dis 12(2):S178-S184 (1990).
Lindberg, A.A., et al., Virulence factors in infections with Bacteroides fragilis: Isolation and of capsular polysaccharide and lipopolysaccharide., Scand J Infect Dis 35:45-52 (1982).
Kasper D.L., et al., Surface antigens as virulence factors in infection with Bacteroides fragilis., Rev Infect Dis 1:278-290 (1979).
Kasper, D.L. et al., The polysaccharide capsule of Bacteroides fragilis subspecies fragilis; Immunochemical and morphologic definition., J Infect Dis 133:79-87 (1976).
Baumann, A. et al., Structural Elucidation of Two Capsular Polysaccharides from One Strain of Bacteroides fragilis Using High-Resolution NMR Spectroscopy; Biochem., 31:4081 (1992).
Vann, W. et al., The Structure of the Capsular Polysaccharide (K 5 Antigen) of Urinary-Tract-Infective Excherischi coli 010:K5:H4 J. of Biochem. 116:359-364, (1981).
DiFabio et al., Structure of the Capsular Polysaccharide Antigen of Type IV Group B Streptococcus; Can. J. Chem. 67:877 (1989).
Fournier, J.M. et al., Isolation of Type 5 Capsular Polysaccharide From Staphylococcus aureus; Ann. Inst. Pasteur/Microbiol. (Paris) 138:561-567 (1987).
Jennings, H.J. et al., Immunochemistry of Groups A, B and C Meningococcal Polysaccharide-Tetanus Toxoid Conjugates, J. Immunol. 123:1011-1018 (1981).
Jennings, H.J. et al., Structure of the Complex Polysaccharide C-Substance from Streptococcus pneumoniae Type 1; Biochem. 19:4712-4719 (1980).
Kasper, D. et al., Capsular Polysaccharides and Lipopolysaccharides from Two Bacteroides fragilis Reference Strains: Chemical and Immunochemical Characterization; J. Bacter. 153:991-997('83).
Kasper, D. et al., Protective Efficacy of Immunization with Capsular Antigen against Experimental Infection with Bacteroides fragilis; J. of Infectious Diseases 140:724-731 (1979).
Kenne, L. et al., Structural Studies of the O-Specific Side-Chains of the Shigella sonnei Phase I Lipopolysaccharide; Carbohydrate Res., 78:119-126, (1980).
Knirel, Y.A. et al., Somatic Antigens of Pseudomonas aeruginosa; European J. of Biochemistry, 167:549-561 (1987).
Knirel, Y.A. et al., The Structure of O-Specific Polysaccharides and Serological Classification of Pseudomonas aeruginosa; Acta Microbiologica Hungarica 35:3-24 (1988).
Lindberg, B. et al., Structural Studies of the Capsular Polysaccharide from Streptococcus pneumoniae Type 1; Carbohydrate Res 78:111-117 (1980).
Onderdonk, A. et al., Evidence for T Cell-dependent Immunity to Bacteroides fragilis in an Intraabdominal Abscess Model; J. Clin Invest. 69:9-16 (1982).
Onderdonk, A. et al., The Capsular Polysaccharide of Bacteroides fragilis as a Virulence Factor: Comparison of the Pathogenic Potential of Encapsulated and Unencapsulated Strains; J. Infect. Diseases 136:82-89 (1977).
Paloeleti et al., Effects of Chain Length on the Immunogenicity of Rabbits of Group B Streptococcus Type III Oligosaccharide-Tetanus Toxoid Conjugates; J. Clin. Invest. 89:203-209 (1992).
Pantosti et al., Immunochemical Characterization of Two Surface Polysaccharides of Bacteroides fragilis; Infection and Immunity 59:2075-2082 (1991).
Pantosti et al., Bacteroides fragilis Strains Express Multiple Capsular Polysaccharides; J. Clin. Microbiol. 31(7):1850 (1993).
Reed, L. et al., A Simple Method of Estimating Fifty Percent Endpoints; Am. J. Hyg. 27:493 (1938).
Shapiro, M. et al, Cellular Control of Abscess Formation: Role of T Cells in the Regulation of Abscesses Formed in Reponse to Bacteroides fragilis; J. Immunol., 137:341-346 (1986).
Shapiro, M. et al., Cellular Immunity to Bacteroides fragilis Capsular Polysaccharide; J. Exp. Med. 154:1188-1197 (1982).
Szu, S.C. et al., Relation Between Structure and Immunologic Properties of the Vi Capsular Polysaccharide; Infection and Imm. 59:4555-4561 (1991).
Taylor, RL. et al., Stoichimetric Depolymerization of Polyuroides and Glycosaminoglycuronans to Monsaccharides following Reduction of their Carbodiimide-Activated Caroxyl Groups; Biochem. 11:1383 (1972).
Tzianabos, A. et al., Abstract, The Am. Society for Microbiology (94th General Mtng.) B-206, May 23-27 (1994).
Tzianabos, A. et al., Abstract, the International Carbohydrate Symposium XVIII, Jul. 21, 1994.
Tzianabos, A. et al., Structural Features of Polysaccharides that Induce Intra-Abdominal Abscesses; Science 262:416-419(1993).
Tzianabos, A. et al., The Capsular Polysaccharide of Bacteroides fragilis Comprises Two Ionically Linked Polysaccharides; J.Biol. Chem. 267:18230-18235 (1992).
Wessels, M.R. et al., Structure and Immunochemistry of an Oligosaccharide Repeating Unit of the Capsular Polysaccharide of Type III Group B Streptococcus; J. Biol. Chem. 262:8262-8267 (1987).
Zaleznik, D. et al., A Soluble Suppressor T Cell Factor Protects Against Experimental Intraabdominal Abscesses; J. Clin. Invest. 75:1023-1027 (1985).
Tzianabos, A. et al., Structural Characteristics of Polysaccharides That Induce Protection against Intra-Abdominal Abcess Formation; Infection and Immunity 62:4881-4886 (1994).
Jennings et al. The Journal of Immunology, vol. 137: 1708-1713, (1986).
Jotwani et al. Microbiol. Immunol., vol. 36: 1041-1049, (1992) Abstract only.
Meisel-Mikolajczyk et al., Archivum Immunologiae et Therapie Experimentalis, vol. 41, pp. 129-131, (1993) abstract only.
The Merck Index (Eleventh Edition), pp. 734-735, (1989).
Kasper Dennis L.
Onderdonk Andrew B.
Tzianabos Arthur O.
Brigham & Women's Hospital Inc.
Kight John
Lee Howard C.
LandOfFree
Capsular polysaccharide immunomodulator does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Capsular polysaccharide immunomodulator, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Capsular polysaccharide immunomodulator will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1006796